Literature DB >> 21034554

Rosiglitazone reduces fatty acid translocase and increases AMPK in skeletal muscle in aged rats: a possible mechanism to prevent high-fat-induced insulin resistance.

Guang-yao Song1, Yu Gao, Chao Wang, Shu-guo Hu, Jing Wang, Dong-ming Qu, Hui-juan Ma.   

Abstract

BACKGROUND: As an agonist of peroxisome proliferator-activated receptor-gamma (PPARγ), rosiglitazone can prevent acute fatty acid-induced insulin resistance in rats, however, the precise mechanisms by which rosiglitazone alleviates insulin resistance induced by high-fat diet need to be further investigated.
METHODS: Wistar rats aged 23-24 weeks were divided into three groups: (1) aged control group (OC), (2) high-fat diet (HF) group and (3) high-fat diet plus rosiglitazone maleate tablets (HF + Rosi) treatment group (n = 20 in each group). Insulin sensitivity was evaluated by conscious hyperinsulinemic-euglycemic clamp technique. mRNA levels of fatty acid translocase (FAT/CD36), AMP-activated protein kinase α1 (AMPKα1), AMPKα2 and acetyl CoA carboxylase (ACC) of rat skeletal muscle were determined using real-time PCR, while muscle carnitine palmitoyltransferase-1 (CPT-1β) was determined using semi-quantitative PCR. Protein expression levels of FAT/CD36, AMPK phosphorylation (reflecting AMPK activity), P-ACC (inversely related with ACC activity) and muscle CPT-1M in rat skeletal muscles were measured using Western blotting.
RESULTS: Aged rats fed by diet rich in fat for more than 8 weeks led to significant increases of plasma lipids, skeletal muscle intramuscular triglyceride and long-chain fatty acyl-CoA (LCACoA) compared to aged rats fed by normal chow diet (OC) (P < 0.05), which might correlate with the lower (reduced by 42.4%) whole body insulin sensitivity in HF rats. FAT/CD36 protein concentrations and mRNA levels increased in untreated HF aged rats (P < 0.01) and high-fat diet induced a significant decrease in P-AMPK, P-ACC, CPT-1M protein concentrations and AMPKα2 and CPT-1β mRNA levels in rat skeletal muscles (P < 0.05). No change in AMPKα1 mRNA levels was observed in the HF group.
CONCLUSION: High-fat diet in aged rats results in a lipid accumulation and subsequent insulin resistance, while rosiglitazone can alleviate the insulin resistance by reducing fatty acid uptake as well as enhancing lipometabolism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21034554

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  7 in total

Review 1.  Roles of AMP-activated protein kinase in Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Keshen Li; Sohel H Quazi; Bin Zhao
Journal:  Neuromolecular Med       Date:  2012-02-26       Impact factor: 3.843

2.  Effects of dietary carbohydrate replaced with wild rice (Zizania latifolia (Griseb) Turcz) on insulin resistance in rats fed with a high-fat/cholesterol diet.

Authors:  Shufen Han; Hong Zhang; Liqiang Qin; Chengkai Zhai
Journal:  Nutrients       Date:  2013-02-15       Impact factor: 5.717

3.  Long-Term Consumption of Platycodi Radix Ameliorates Obesity and Insulin Resistance via the Activation of AMPK Pathways.

Authors:  Chae Eun Lee; Haeng Jeon Hur; Jin-Taek Hwang; Mi Jeong Sung; Hye Jeong Yang; Hyun-Jin Kim; Jae Ho Park; Dae Young Kwon; Myung-Sunny Kim
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-05       Impact factor: 2.629

4.  Rosiglitazone enhances apolipoprotein M (Apom) expression in rat's liver.

Authors:  Guanghua Luo; Yuehua Feng; Jun Zhang; Qinfeng Mu; Yuanping Shi; Li Qin; Lu Zheng; Maria Berggren-Söderlund; Peter Nilsson-Ehle; Xiaoying Zhang; Ning Xu
Journal:  Int J Med Sci       Date:  2014-07-29       Impact factor: 3.738

5.  The molecular basis of the antidiabetic action of quercetin in cultured skeletal muscle cells and hepatocytes.

Authors:  Hoda M Eid; Abir Nachar; Farah Thong; Gary Sweeney; Pierre S Haddad
Journal:  Pharmacogn Mag       Date:  2015 Jan-Mar       Impact factor: 1.085

6.  Role of Peroxisome Proliferator-Activated Receptor-γ in Vascular Inflammation.

Authors:  Kousei Ohshima; Masaki Mogi; Masatsugu Horiuchi
Journal:  Int J Vasc Med       Date:  2012-07-24

7.  PPARγ agonists delay age-associated metabolic disease and extend longevity.

Authors:  Lingyan Xu; Xinran Ma; Narendra Verma; Luce Perie; Jay Pendse; Sama Shamloo; Anne Marie Josephson; Dongmei Wang; Jin Qiu; Mingwei Guo; Xiaodan Ping; Michele Allen; Audrey Noguchi; Danielle Springer; Fei Shen; Caizhi Liu; Shiwei Zhang; Lingyu Li; Jin Li; Junjie Xiao; Jian Lu; Zhenyu Du; Jian Luo; Jose O Aleman; Philipp Leucht; Elisabetta Mueller
Journal:  Aging Cell       Date:  2020-11-21       Impact factor: 9.304

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.